Sponsor pipeline

Kartos Therapeutics, Inc. clinical trial pipeline

Get alerts when Kartos Therapeutics, Inc.'s trials change

2 active trials 2 recruiting 2 Phase 3 2 disease areas

Data updated daily from ClinicalTrials.gov, last refresh 2026-08-28

Active trials by phase

Phase 2/3
1
Phase 3
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT06479135 Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With… Myelofibrosis Recruiting 2025-09-25
Phase 2/3
NCT05797831 Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial… Endometrial Cancer Recruiting 2024-05-02

Disease areas by active trials

Endometrial Cancer (1) · Myelofibrosis (1)

Get alerts when Kartos Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free